• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVEDERM ULTRA 3/SMILE (VOLUME UNKNOWN); IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVEDERM ULTRA 3/SMILE (VOLUME UNKNOWN); IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number UNK JUVEDERM ULTRA 3/SMILE
Device Problems Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
Patient Problems Nodule (4551); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/08/2023
Event Type  Injury  
Manufacturer Narrative
Continued h.6.Type of investigation code: b15, b17, b20.Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Healthcare professional (hcp) reported that a patient was injected in nasogenian folders and lips with first injection of juvéderm® volbella¿ with lidocaine.2nd injection 9 days later, 3rd injection 13 days later and 4th injection 14 days later only in the lips.8 weeks later, patient experienced inflammation on lips and nodules and philtrum ridges.Patient was treated with ibuprofen.To prevent streptococcus infection, patient was prescribed ciprofloxacine and zamene.Symptoms ongoing / unresolved.This is the same event and the same patient reported under mdr id#: 3005113652-2023-00601 (abbvie complaint#: (b)(4), mdr id#: 3005113652-2023-00602 (abbvie complaint#: (b)(4), and mdr id#: 3005113652-2023-00604 (abbvie complaint#: (b)(4).This mdr is being submitted for the suspect product, 3rd injection with juvéderm® volbella¿ with lidocaine.
 
Event Description
Healthcare professional reported problem solved by removing juvéderm® volbella¿ with injected hyaluronidase in the nodules of the lips.A week ago, patient noticed the appearance of new nodules and induration at palpation in the treated zones with juvederm 3.The patient prefers for now not to remove the product as practically there is no aesthetic modification visible and was very happy with the obtained results so far".
 
Manufacturer Narrative
Additional, corrected, and/or changed data: b5, h6.
 
Event Description
Additional information clarify that patient was injected with a single syringe of juvéderm® volbella¿ (captured in mdr id# 3005113652-2023-00604 with abbvie complaint #(b)(4) that was used in its entirety by spreading it on the lips and ridges of the philtrum.This injection was noted to be juvéderm® ultra 3 in nasogenian folders and lips with good results.This device does not meet reporting requirements aligned with medical device reporting as the device is non-pma approved.
 
Manufacturer Narrative
Corrected data: b.2., b.5., d.1., d.4., g.4., h.1., h.6.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVEDERM ULTRA 3/SMILE (VOLUME UNKNOWN)
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer Contact
terry ingram
12331-a riata trace parkway
building 3
austin, TX 78727
8479366324
MDR Report Key17386106
MDR Text Key319649036
Report Number3005113652-2023-00603
Device Sequence Number1
Product Code LMH
Combination Product (y/n)Y
Reporter Country CodeSP
PMA/PMN Number
-
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/02/2024
Device Catalogue NumberUNK JUVEDERM ULTRA 3/SMILE
Device Lot Number1000500549
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/11/2023
Initial Date FDA Received07/24/2023
Supplement Dates Manufacturer Received09/28/2023
11/03/2023
Supplement Dates FDA Received10/13/2023
11/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/02/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
Patient SexFemale
-
-